ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ÉúÃü¿ÆÑ§´ÞöÁ½ÌÊÚÍŶÓÓë¹ãÖÝÒ½¿Æ´óѧÕÔ½ð´æ½ÌÊÚÍŶÓÕ¹ÏÖйڲ¡¶¾ºËÒ¿ÇÂѰ×ͨ¹ýÏà±äÔö½øËÞÖ÷Ñ×Ö¢·´Ó³µÄлúÖÆ

¸å¼þȪԴ£º£º£ºÉúÃü¿ÆÑ§Ñ§Ôº ÔĶÁÁ¿£º£º£º

йڲ¡¶¾£¨severe acute respiratory syndrome coronavirus 2, SARS-CoV-2£©Òý·¢µÄйڷÎÑ×£¨coronavirus disease 2019, COVID-19£©ÒßÇéÏÖÔÚÈÔÔÚÈ«ÇòËÁŰ¡£¡£Ñо¿Åú×¢£¬£¬£¬²¡¶¾ÒýÆðµÄÒì³£Ñ×Ö¢·´Ó³ÓëCOVID-19¼²²¡Ï£ÍûÇ×½üÏà¹Ø¡£¡£ÔÚ²¡¶¾Ñ¬È¾Àú³ÌÖУ¬£¬£¬²¡¶¾»áÓÕµ¼»úÌåÃâÒßϵͳ±¬·¢Ç÷»¯Òò×Ó¼°Ñ×Ö¢Òò×Ó£¬£¬£¬ÕÐļÃâÒßϸ°ûɨ³ý²¡¶¾¡£¡£È»¶ø£¬£¬£¬ÔÚ²¿·Ö»¼ÕßÖУ¬£¬£¬²¡¶¾½éµ¼µÄÃâÒß·´Ó³»áÌ«¹ý¼¤»î£¬£¬£¬µ¼ÖÂÑÏÖØµÄÑ×Ö¢·´Ó³£¬£¬£¬²¢±¬·¢¡°Ñ×Ö¢Òò×ӷ籩¡±£¬£¬£¬Ôì³É×éÖ¯ËðÉË£¬£¬£¬¶àÆ÷¹ÙË¥½ß£¬£¬£¬ÉõÖÁ»¼ÕßéæÃü¡£¡£Òò´Ë£¬£¬£¬Ì½ÌÖйڲ¡¶¾ÒýÆðÌ«¹ýÑ×Ö¢µÄ;¾¶¼°»úÖÆ£¬£¬£¬²¢ÒÔ´ËΪ»ù´¡¼õÇáйڲ¡¶¾ÒýÆðµÄÑ×Ö¢·´Ó³£¬£¬£¬ÓÐÍû¸ÄÉÆ»¼ÕßÁÙ´²Ô¤ºó¡£¡£È»¶ø£¬£¬£¬Ð¹ڲ¡¶¾Ñ¬È¾Àú³ÌÖ줻îËÞÖ÷Ñ×Ö¢·´Ó³µÄÏêϸ·Ö×Ó»úÖÆÏÖÔÚÉв»Ã÷È·¡£¡£

ºËÒ¿ǣ¨N£©ÂѰ×ÊǹÚ×´²¡¶¾Öк¬Á¿ºÍÊØ¾ÉÐÔ×î¸ßµÄÂѰף¬£¬£¬ÊDz¡¶¾Á£×ӵĽ¹µãÒòËØ¡£¡£NÂѰײ»µ«ÄÜʶ±ð²¡¶¾RNA²¢½«Æä°ü×°³ÉºËÌǺËÂѰף¨RNP£©¸´ºÏÌ壬£¬£¬»¹ÄÜͨ¹ýÓ벡¶¾»òËÞÖ÷ÂѰ×Á¬Ïµ£¬£¬£¬¼ÓÈ벡¶¾×ªÂ¼¡¢¸´ÖÆ¡¢ÃâÒßµ÷ÀíµÈ¶à¸öÀú³Ì¡£¡£½üÊýÔÂÄÚ£¬£¬£¬º£ÄÚÍâ¶à¸öÑо¿×é·¢Ã÷йڲ¡¶¾NÂѰ×ÄÜÓ벡¶¾RNAÐγɡ°Òº-ÒºÏàÊèÉ¢¡±ÕâÒ»Õ÷Ïó1-4¡£¡ £¡£¡°Òº-Òº¡±ÏàÊèÉ¢£¨LLPS£©ÊÇÔÚÉúÃü¿ÆÑ§ÁìÓòѸËÙ¿ªÕ¹ÆðÀ´µÄп´·¨¡£¡£ÔÚÒ»¶¨Ìõ¼þÏ£¬£¬£¬ÈÜÒºÖеÄÉúÎï´ó·Ö×Ó»áÒòÏ໥×÷Óöø¸ß¶ÈȺ¼¯Å¨Ëõ£¬£¬£¬´ÓͨË×ÈÜÒºÏàÖÐÊèÉ¢³öÀ´£¬£¬£¬ÐγÉ×ÔÁ¦¶øÕ³³íµÄÒºÌåÏࣨLLPSÒºµÎ£©¡£¡£ÉúÎï´ó·Ö×ÓÏàÊèÉ¢±»ÒÔΪÊǽ鵼ϸ°ûÄÚÎÞĤϸ°ûÆ÷¼°ÎÞĤ¿ÅÁ£ÐγɵÄÖ÷Òª»úÖÆ¡£¡£LLPSÏà¼Ì±»·¢Ã÷¼ÓÈë»ùÒòµ÷¿Ø¡¢ÐźÅתµ¼¡¢Ó¦¼¤·´Ó³µÈ¶à¸öÒªº¦Ï¸°ûÀú³Ì£¬£¬£¬²¢Ñ¸ËÙ³ÉΪÉúÃü¿ÆÑ§ÁìÓòµÄÑо¿Ç°ÑØ¡£¡£ÄÇôйڲ¡¶¾NÂѰ×ÐγɵÄLLPSÊÇ·ñ¼ÓÈ벡¶¾½éµ¼µÄÑ×Ö¢·´Ó³Àú³ÌÄØ£¿

ngµç×ÓÓÎÏ·ÉúÃü¿ÆÑ§Ñ§Ôº´ÞöÁ½ÌÊÚÍŶӺ͹ãÖÝÒ½¿Æ´óѧºôÎü¼²²¡¹ú¼ÒÖØµãʵÑéÊÒÕÔ½ð´æ½ÌÊÚÍŶÓÏàÖú£¬£¬£¬¸ÃÑо¿ÔÚйڲ¡¶¾NÂѰ×Ó벡¶¾RNAÁ¬ÏµÐγÉLLPSµÄ»ù´¡ÉÏ£¬£¬£¬½øÒ»²½Ì½ÌÖÁËйڲ¡¶¾NÂѰ×LLPSÓëËÞÖ÷Ñ×Ö¢·´Ó³µÄ¹ØÁªÇéÐΣ¬£¬£¬Õ¹ÏÖÁËйڲ¡¶¾Ê¹ÓÃNÂѰ×LLPSÔö½øËÞÖ÷NF-¦ÊBͨ·µÄÌ«¹ý»î»¯¼°Ñ×Ö¢·´Ó³µÄ·Ö×Ó»úÖÆ¡£¡£

´Ëǰ£¬£¬£¬´ÞöÁ½ÌÊÚÍŶӼ°º£ÄÚÍâ²î±ðÍŶӵÄÑо¿Ð§¹ûÅú×¢£¬£¬£¬Ð¹ڲ¡¶¾Öжà¸öÂѰ׼ÓÈëÒÖÖÆËÞÖ÷¹ÌÓÐÃâÒß·´Ó³5-8¡£¡£±¾Ñо¿·¢Ã÷£¬£¬£¬ÓëÒÑÍù¾ßÓиºÏòµ÷¿ØËÞÖ÷ÃâÒߵIJ¡¶¾ÂѰײî±ð£¬£¬£¬Ð¹ڲ¡¶¾µÄNÂѰ×ÄÜÔÚ²¡¶¾Ñ¬È¾ºóÆÚÔö½øËÞÖ÷µÄÑ×Ö¢·´Ó³£¬£¬£¬Õâ¿ÉÄÜÓëйڲ¡¶¾ÒýÆðµÄϸ°ûÒò×ӷ籩Ïà¹Ø¡£¡£½øÒ»²½»úÖÆÑо¿Åú×¢£¬£¬£¬Ð¹ڲ¡¶¾NÂѰ×ÄÜÕÐļNF-¦ÊBͨ·ÖеÄÒªº¦¼¤Ã¸TAK1¼°IKK¦Â£¬£¬£¬Ôö½øTAK1ÓëIKK¦ÂµÄÏ໥×÷Ó㬣¬£¬²¢¼¤»îIKK¦ÂÁ×Ëữ¡£¡£Í¨¹ýÔö½øTAK1ÓëIKK¦ÂÏ໥Á¬Ïµ£¬£¬£¬NÂѰ×Ôö½øËÞÖ÷NF-¦ÊBͨ·µÄ¼¤»î£¬£¬£¬ÓÕµ¼Ï¸°ûÉøÍ¸´ó×Ú´ÙÑ×ÐÔϸ°ûÒò×Ó£¬£¬£¬°üÀ¨IL-6¡¢IL-1¦Â¡¢IL-8ºÍTNF¦ÁµÈ¡£¡£

½øÒ»²½Ñо¿Åú×¢£¬£¬£¬Ð¹ڲ¡¶¾µÄNÂѰ×ÄÜÁ¬Ïµ²¡¶¾µ¥Á´¼°Ë«Á´µÄRNA²¢Ðγɡ°Òº-ÒºÏàÊèÉ¢¾ÛÕûÌ塱¡£¡£Ï¸°ûÄÚ¼°ÌåÍâÖØ¹¹ÊµÑéÅú×¢£¬£¬£¬²¡¶¾RNA-NÂѰ×ÏàÊèÉ¢¾ÛÕûÌåÄÜÕÐļTAK1¼°IKK¦Â£¬£¬£¬²¢°ÑTAK1ÓëIKK¦Â´øÈëRNA-NÂѰ׾ÛÕûÌåÖС£¡£¶øRNA-NÂѰ׵ÄÏàÊèÉ¢¾ßÓÐÒ»¶¨Ñ¡ÔñÐÔ£¬£¬£¬RNA-NÂѰ×ÄܰÑTAK1´øÈëÏàÊèÉ¢¾ÛÕûÌåÄÚ£¬£¬£¬Ðγɼ¤»î½¹µã£¬£¬£¬Í¬Ê±°ÑIKK¦ÂÁ¬ÏµÔÚÏàÊèÉ¢ÒºµÎµÄÍâΧ£¬£¬£¬ÐγÉÌØÊâµÄÍâ»·½á¹¹£¬£¬£¬ÕâÖֽṹ¿ÉÄÜÔö´óIKK¦ÂÓëÏÂÓηÖ×ÓµÄÁ¬ÏµÃæ»ý£¬£¬£¬²¢ÔöÇ¿IKK¦ÂµÄ¼¤Ã¸»îÐÔ£¨Èçͼ£©¡£¡£±ðµÄ£¬£¬£¬Ê¹ÓÃ1,6¼º¶þ´¼£¨LLPSÒÖÖÆ¼Á£©´¦ÀíÒÖÖÆNÂѰ×ÏàÊèÉ¢Ðγɣ¬£¬£¬²»µ«Ï÷Èõ²¡¶¾Ñ¬È¾Àú³ÌÖÐTAK1ÓëIKK¦ÂµÄÏ໥×÷Ó㬣¬£¬²¢ÇÒÄÜÒÖÖÆÐ¹ڲ¡¶¾Ñ¬È¾ÒÖÖÆµÄÑ×Ö¢·´Ó³¼°Ñ×Ö¢Òò×ÓÊÍ·Å¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ͼ£º£º£ºÐ¹ڲ¡¶¾ºËÒ¿ǣ¨N£©ÂѰ×ͨ¹ýÐγÉLLPSÕÐļTAK1¼°IKK¦ÂÔö½øËÞÖ÷NF-¦ÊBͨ·̫¹ý¼¤»î£º£º£ºa-b£¬£¬£¬´¿»¯Ð¹ڲ¡¶¾NÂѰס¢TAK1¼°IKK¦Â£¬£¬£¬ÌåÍâÖØ¹¹ÏàÊèɢϵͳ£»£»£»c£¬£¬£¬Ï¸°ûÄÚйڲ¡¶¾NÂѰ×Ôö½øTAK1ÓëIKK¦ÂÐγɵġ°LLPSÒºµÎ¡±£»£»£»d£¬£¬£¬Ð¹ڲ¡¶¾NÂѰ×ͨ¹ýLLPSÔö½øNF-¦ÊBͨ·»úÖÆÊ¾Òâͼ¡£¡£

×ÛÉÏËùÊö£¬£¬£¬¸ÃÑо¿·¢Ã÷ÁËйڲ¡¶¾¼°±àÂëµÄNÂѰ׶ÔËÞÖ÷NF-¦ÊBͨ·¼°Ñ×Ö¢·´Ó³µÄÔö½ø×÷Ó㬣¬£¬Õ¹ÏÖÁËNÂѰ×ͨ¹ýLLPSÕÐļNF-¦ÊBÒªº¦¼¤Ã¸TAK1¼°IKK¦Â²¢ÐγÉÏàÊèÉ¢¸´ºÏÌåµÄ·Ö×Ó»úÖÆ£¬£¬£¬²¢ÎªÐ¹ڷÎÑ×ÖÎÁÆÌá³ö°ÐÏòÏàÊèÉ¢µÄÐÂÐÍÒÖÑ×Õ½ÂÔ¡£¡£

¸ÃÑо¿ÔÚSignal Transduction and Targeted TherapyÔÓÖ¾ÖнÒÏþÁËÌâΪ¡°RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-¦ÊB hyper-activation and inflammation¡±µÄѧÊõÑо¿¡£¡£ngµç×ÓÓÎÏ·ÉúÃü¿ÆÑ§Ñ§Ôº´ÞöÁ½ÌÊÚ£¬£¬£¬¹ãÖÝÒ½¿Æ´óѧºôÎü¼²²¡¹ú¼ÒÖØµãʵÑéÊÒÕÔ½ð´æ½ÌÊÚΪ±¾ÏîÊÂÇéµÄÅäºÏͨѶ×÷Õß¡£¡£ngµç×ÓÓÎÏ·ÉúÃü¿ÆÑ§Ñ§ÔºÎéÒ«ÐǸ±Ñо¿Ô±¡¢ÂíÁ販ʿ¡¢²Ì˼»Û˶ʿºÍ¹ãÖÝÒ½¿Æ´óѧºôÎü¼²²¡¹ú¼ÒÖØµãʵÑéÊÒׯÕ䲩ʿΪ¸ÃÂÛÎĵÄÅäºÏµÚÒ»×÷Õß¡£¡£¸ÃÑо¿»ñµÃÁ˹ú¼ÒÖØµã»ù´¡Ñо¿¿ªÕ¹ÍýÏë¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÈÏîÄ¿×ÊÖú¡£¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://rdcu.be/cjijx

¡¾ÍøÕ¾µØÍ¼¡¿